Welcome to LookChem.com Sign In|Join Free
  • or
3'-Methanesulfonyl-biphenyl-4-carboxylic acid is a chemical compound with the molecular formula C14H12O4S. It is a derivative of biphenyl, featuring a carboxylic acid group and a methanesulfonyl group at specific positions. 3'-Methanesulfonyl-biphenyl-4-carboxylic acid is recognized for its unique structure and reactivity, which makes it a valuable building block in organic synthesis and pharmaceutical research.

16734-97-7

Post Buying Request

16734-97-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16734-97-7 Usage

Uses

Used in Pharmaceutical Research:
3'-Methanesulfonyl-biphenyl-4-carboxylic acid is utilized as a key intermediate in the development of new drugs. Its unique chemical properties allow it to be a promising candidate for the creation of pharmaceuticals with novel mechanisms of action and therapeutic potential.
Used in Organic Synthesis:
In the field of organic synthesis, 3'-Methanesulfonyl-biphenyl-4-carboxylic acid serves as a versatile building block. It is used to construct more complex organic molecules, which can be applied across various chemical and material industries.
Used in Material Development:
Due to its interesting physical and chemical properties, 3'-Methanesulfonyl-biphenyl-4-carboxylic acid is also employed in the development of new materials. Its incorporation can lead to advancements in material sciences, potentially enhancing the performance of existing materials or creating new ones with specific applications.

Check Digit Verification of cas no

The CAS Registry Mumber 16734-97-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,7,3 and 4 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 16734-97:
(7*1)+(6*6)+(5*7)+(4*3)+(3*4)+(2*9)+(1*7)=127
127 % 10 = 7
So 16734-97-7 is a valid CAS Registry Number.

16734-97-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-(3-methylsulfonylphenyl)benzoic acid

1.2 Other means of identification

Product number -
Other names 3'-Methanesulfonyl-biphenyl-4-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16734-97-7 SDS

16734-97-7Downstream Products

16734-97-7Relevant academic research and scientific papers

SEROTONIN 5-HT2B INHIBITORY COMPOUNDS

-

, (2020/10/18)

The compounds of the invention, as described herein, are novel serotonin 5-HT2B antagonists useful for the treatment of myxomatous mitral valve degeneration (MMVD), congestive heart failure (CHF), and/or asymptomatic heart failure in animals, preferably c

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

-

Page/Page column 22, (2010/03/31)

The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases

HISTAMINE H3 RECEPTOR AGENTS, PREPARATION AND THERAPEUTIC USES

-

Page/Page column 54, (2008/06/13)

The present invention discloses novel compounds of Formula (I) or pharmaceutically acceptable salts thereof, which have histamine-H3 receptor antagonist or inverse agonist activity, as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising compounds of Formula (I) as well as methods of using them to treat obesity, cognitive deficiencies, narcolepsy, and other histamine H3 receptor-related diseases

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 16734-97-7